glp-1 eye rot Weight loss drugs linked to higher risk of damage in diabetic patients | Diabetes GLP-1 Drugs and Diabetic Eye

The FDA has issued multiple rounds of warning letters to telehealth companies marketing compounded GLP-1 products

Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

A normal, healthy stool generally resembles type 4 on the stool chart: smooth, soft, and sausage-like

Int J Clin Pharmacol Ther 45(2):114120 le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L et al (2017) 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

doi: 10.1126/science.1072891 117 PolsTWHNomuraMHarachTSassoGLOosterveerMHThomasCet al

This trial will assess the therapy over a three-month period on overweight cats